29 Oct 2010 11:34

Â
Instem Life Science Systems plc ('the Company')
29 October 2010
Â
VOTING RIGHTS AND CAPITAL
Â
In conformity with the Disclosure and Transparency Rules we would like to notify the market of the following:Â
Â
The Company's issued share capital consists of 11,714,286 ordinary shares with a nominal value of 10p each ('Ordinary Shares'). The Company does not hold any Ordinary Shares in Treasury.
Â
Therefore, the total number of voting rights in the Company is 11,714,286
Â
The figure of 11,714,286 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.
Â
For further information, please contact:
Â
Instem Life Science Systems plc | +44 (0) 1785 825600 |
Phil Reason, CEO | |
Jim McLauchlan, CFO | |
Brewin Dolphin - Financial Advisor, Broker & NOMAD | +44 (0) 0845 213 4730 |
Mark Brady | |
Sean Wyndham-Quin | |
Rickitt Mitchell - Joint Financial Advisor to the Company | +44 (0) 161 834 0600 |
Matthew Bryden-Smith | |
Neil Mitchell | |
Threadneedle Communications | +44 (0) 20 7653 9850 |
Caroline Evans-Jones | |
Fiona Conroy | |
Josh Royston |
Â
Â
Follow the stocks